A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin
NCT01447797
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
HCP0912 / Irbesartan and Atorvastatin
Sponsor
Hanmi Pharmaceutical Company Limited